Reportlinker.com announces that a new market research report is available in its catalogue:

United States Anesthesia and Respiratory Devices Market Outlook to 2017 – Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others

The report provides key market data on the United States Anesthesia and Respiratory Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within eight market categories – Airway and Anesthesia Devices, Anesthesia Machines, Pain Management Devices, Regional Anesthesia Disposables, Respiratory Devices, Respiratory Disposables, Respiratory Measurement Devices and Sleep Apnea Diagnostic Systems. Read the rest of this entry

If you’re suffering from sleep apnea and if you are also a habitual snorer a robotic polar bear pillow might be something worth checking out. It has been named as “Jukusui-kun”, and was developed by Wasaeda University’s Kabe Lab in Japan.

The major objective of developing this robotic polar bear pillow is to help those who suffer from sleep apnea and heavy snoring by gently tickling the user’s face.

By tickling the user’s face, this would cause the user to roll onto their side while remaining in a state of deep sleep, or so it has been reported. Rolling onto your side while sleeping has been said to help reduce snoring, so while some of us find it hard to actively sleep on our sides during a deep state of sleep, this is where Jukusui-kun comes in. Read the rest of this entry

WideMed Ltd.  has obtained EU CE Mark for its mobile sleep apnea system Morpheus Ox for home use. The system is based on a device made by Nonin Medical Inc. and WideMed’s mobile application and Morpheus platform for monitoring sleep apnea.

The device’s interface receives photoplethysmography (PPH) signals, which are collated by an application developed by the company for mobile telephones.

The Morpheus Ox system can monitor, measure, and analyze snores and send accurate data to a physician about the patient’s respiration, sleep apnea, oxygen levels, and heartbeat during the night.

WideMed said that it plans to begin marketing the Morpheus Ox system in Europe and the Far East during the fourth quarter, and that it undergoing regulatory procedures with the Food and Drug Administration (FDA) to approve the device for marketing in the US.

SleepApneaDisorder/[ Press Release ]/ Minneapolis, USA/  – SLEEP 2011 will bring current research and clinical practices to the forefront for sleep specialists from around the world this week at the Associated Professional Sleep Societies, LLC annual meeting. And Royal Philips Electronics (NYSE: PHG, AEX: PHI) will demonstrate the latest advances in sleep with the premiere of “Pathway to Compliance.” The interactive showcase features the latest breakthroughs for diagnosing, treating and managing the entire spectrum of sleep-disordered breathing patients and guides them on their journey to better sleep. “Tremendous strides have been made to deepen our understanding of sleep,” says John Frank, Sr. Vice President, General Manager, Sleep and Respiratory Care, Philips Home Healthcare Solutions. “There is growing evidence of co-morbidities such as diabetes, obesity, and cardiovascular disease. As allies in better sleep and breathing, we are committed to meeting these challenges with intelligent solutions. With “Pathway to Compliance,” we will show how new advances are making the future of sleep and therapy compliance a reality for patients and clinicians.” Read the rest of this entry

Sleep apnea is a disorder that results from interrupted breathing during sleep. Indicators of this condition are snoring and tiredness despite getting a full night’s rest.

Sleep apnea does not immediately present itself as a serious problem, but it may cause heart problems and other health complications. Because of this, it is important to seek treatment for sleep apnea.

The term “sleep apnea” is an umbrella term that can refer to different versions of the disorder. As a result, treatment for sleep apnea can vary from patient to patient. Treatment methods include continuous positive airway pressure, adjustable airway pressure devices, oral appliances, supplemental oxygen bi-level positive airway pressure, and adaptive servo-ventilation—to name a few. In severe cases, surgery may be necessary.

When diagnosing or treating sleep apnea, your doctor may first recommend some lifestyle changes before prescribing medication. Some helpful lifestyle changes, such as quitting smoking and losing weight, are effective treatments.

Information on other at-home treatments, such as changing sleeping positions, are also helpful. However, be sure to consult your doctor first.

The full year results for Fisher & Paykel Healthcare are due on Wednesday and those of Fisher & Paykel Appliances will be released on Friday.

Analysts will be closely watching Fisher and Paykel Healthcare’s sleep apnea range, and what impact the high New Zealand dollar could have on the business during the year ahead. The medical equipment manufacturer’s guidance for the full year is for a profit of between $60 and $63 million.

But Forsyth Barr senior analyst Guy Halwright says this may be pushed slightly higher due to the New Zealand dollar over the past six months.

He says the sleep apnea market has been slower than previously, but it’s unclear whether this is simply a lingering effect of the economic crisis and the slow American economy.He says the high New Zealand currency is the main problem facing Fisher & Paykel. Read the rest of this entry

Reportlinker announces that a new market research report The Respiratory Diagnostic Devices Market Outlook to 2016 . This report covers the epidemiology of the key respiratory disorders forecasting this to 2016. The report then goes on to give in depth analysis of the major diagnostic technologies including: blood gas analyzers, pulse oximeters, spirometers, full spectrum testing equipment, and polysomnographs. For each of these technology types an overview is given of the leading players and their products.

Based on its recent analysis of the neurostimulation for sleep apnea market, Frost & Sullivan recognizes ImThera Medical, Inc. with the 2011 North American Frost & Sullivan Award for Technology Innovation for its pioneering sleep apnea device, the aura6000™.

Continuous positive airway pressure (CPAP) treatment, the gold standard for treating obstructive sleep apnea (OSA), has poor patient compliance due to the inconvenience involved. ImThera is one of the few companies to have devised a neurostimulation device for treating OSA that targets CPAP non-compliant patients worldwide (at least 46 percent of patients according to market data) and can also be used for others as a second line of therapy for OSA. Read the rest of this entry

The disaster in Japan has the world’s attention. Millions of people watch in horror as the people of Japan struggle to get through day by day. Japan suffered a 1-2-3 punch in the events of an earthquake, then a tsunami, and finally nuclear radiation worries. Many different teams of rescuers have been sent over to Japan to aid in the search and rescue efforts. These teams have been tasked with the responsibility to search for both survivors and bodies in various towns and villages along the east coast of Japan. What has become an almost requirement for these teams are tools that are both portable and easy to use. 

Hundreds of  Pulse Oximeters have been donated by many manufacturers and serving companies to Japan .for the emergency responders. The pulse oximeter, is a portable device used to measure the blood oxygen saturation and pulse rate of individuals. These pulse oximeters are not your old traditional tabletop units, but rather fingertip units which are smaller than your average mobile phone. A fingertip pulse oximeter operates on standard AA batteries, and provides its readings of blood oxygen saturation and pulse rate within seconds. Read the rest of this entry

Research and Markets has announced the addition of the “India Patient Monitoring and Diagnostic Systems Market Opportunity and Growth Trend Forecast till 2016” report to their offering.

The Market Intelligence report provides critical market data for India patient monitoring and diagnostics market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It’s vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. It covers important categories such as blood pressure monitors, cardiovascular monitoring systems, blood glucose monitoring devices, hearing diagnostics, micro-electromechanical systems multiparameter patient monitors, remote monitoring systems, sleep apnea diagnostic systems and wireless hospital ambulatory monitors. Market Size: Market size in terms of value ($) and volume (units), for each level of segmentation from 2005 to 2010 and forecast till 2016.

Research and Markets has announced the addition of the “US Patient Monitoring and Diagnostic Systems Market Opportunity and Growth Trend Forecast till 2016” report to their offering.

The Market Intelligence report provides critical market data for US  Patient monitoring and diagnostics market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of  companies at sector and category level. It’s vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in  mapping market size, competition, understanding historic and future  growth trends. It covers important categories such as blood pressure monitors, cardiovascular monitoring systems, blood glucose monitoring devices, hearing diagnostics, micro-electromechanical systems  multiparameter patient monitors, remote monitoring systems, sleep apnea diagnostic systems and wireless hospital ambulatory monitors.

• Market Size: Market size in terms of value ($) and volume (units), for each level of segmentation from 2005 to 2010 and forecast till 2016.
• Market Growth: Market growth in terms of value ($) and volume (units),   for each level of segmentation from 2005 to 2010 and forecast till 2016.
• Competitive Analysis: Market share (%) of companies is covered at  sector and category level for 2010.
• Pricing Analysis: Average selling price ($) for each product type from 2005 – 2010 and forecast till 2016.

Cross category comparison and cross sub-category comparison – Forecast and historic market growth and market size comparison for various  categories and sub-categories from 2005 to 2010 and 2010 to 2016.

Air Liquide Canada today celebrates 100 years of operation across Canada. It opened the first air separation facility in 1911 in Montreal’s east end. Air Liquide Canada now has over 2200 employees working in more than 65 sites from the Atlantic to the Pacific. Through innovative solutions based on continually enhanced technologies, Air Liquide Canada is a key player in the manufacturing of numerous products that people use every day – literally pulling solutions out of thin air to preserve the environment and enhance quality of life. Air Liquide Canada is a subsidiary of the Air Liquide Group, deeply involved in the field of medical gases and home health programs through its subsidiary, VitalAire Canada.

The expertise of VitalAire Canada respiratory healthcare products and services is based on over 40 years of experience. With more than 80 clinics and 150 healthcare professionals, VitalAire is one of Canada’s leaders in home oxygen therapy services, sleep apnea programs and treatment of obstructive sleep apnea syndrome. Its medical gases and hospital services unit meets the needs of the Canadian market and currently supplies over 2000 hospitals and clinics across the country.

The PC-60D2 Pediatric Pulse Oximeter measures SpO2 (percentage of oxygen saturation in the blood) and pulse rate of children with accuracy and ease. The PC-60D2 offers a special design and chipset technology specifically manufactured for a kid’s finger. It uses a customized pediatric oximetry sensor adjusted for children’s skin to ensure accurate readings. Small and compact, it provides complete oximetry solutions while still able to fit in your pocket.

“It is of the greatest importance to parents to be able to monitor their children’s health conditions including asthma ,sleep apnea, or heart arrhythmia wherever they go,” said Dr. Khanna of the Lavale Clinic based in Cumberland, MD. “The PC-60D2 Pulse Oximeter is the perfect tool for parents to monitor their children on the go as they simply measure the child’s SpO2 and pulse rate and subsequently share the results with for professional diagnosis and treatement.”

The PC-60D2 Oximeter is a widely used medical device in health-care facilities, including hospitals, outpatient surgery centers, physician offices, dentist offices, emergency and ambulatory situations, as well as home diagnostics for monitoring of children’s health.

Instant Diagnostic Systems (IDS), an Independent Diagnostic Testing Facility (IDTF) that specializes in home-based diagnostic testing, has earned The Joint Commission’s Gold Seal of Approval for accreditation. The accreditation award recognizes IDS’s dedication to continuous compliance with The Joint Commission’s standards in ambulatory health, telehealth, and sleep studies.

Mark Sorrells, president and CEO of IDS, said, ”Although accreditation is not a requirement for our type of health care facility in most jurisdictions, IDS felt it was important to pursue accreditation through The Joint Commission to demonstrate our commitment to providing high-quality health care to patients nationwide.”

Since 1975, The Joint Commission has developed standards for outpatient ambulatory care organizations. These standards address important functions relating to the care of patients and the management of an ambulatory care organization; and are developed in consultation with health care experts, providers, measurement experts, and patients.

“As the largest provider of overnight oximetry and home sleep testing in the United States, we hold ourselves accountable to a higher standard to provide high-quality, cost-effective diagnostic tests that patients can self-administer in their own homes,” Sorrells said. “With as many as 20 million Americans currently undiagnosed with sleep apnea, the number of home sleep tests performed by IDS is growing rapidly. Primary care physicians realize they can order a home sleep test and provide treatment to many of their patients without the patient going to an in-lab facility for the test at a significantly greater cost.“

Research and Markets has announced the addition of the “Germany Patient Monitoring and Diagnostic Systems Market Opportunity and Growth Trend Forecast till 2016″ report to their offering.

The Market Intelligence report provides critical market data for Germany patient monitoring and diagnostics market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level.

Its vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends.

It covers important categories such as blood pressure monitors, cardiovascular monitoring systems, blood glucose monitoring devices, hearing diagnostics, micro-electromechanical systems multiparameter patient monitors, remote monitoring systems, sleep apnea diagnostic systems and wireless hospital ambulatory monitors.